Literature DB >> 8692546

Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.

L X Cubeddu1.   

Abstract

Emesis is a common side effect of chemotherapeutic drugs. Cisplatin, nitrogen mustard and dacarbazine induce increases in urinary 5-hydroxyindoleacetic acid (5-HIAA) in parallel with the development of the period of emesis which is sensitive to 5-HT3 receptor antagonists ('acute emesis'). It is suggested that these cytotoxics release serotonin from enterochromaffin cells, which then acts on 5-HT3 receptors to trigger the emetic response. Cyclophosphamide, on the other hand, induces a modest emetic response, partly sensitive to 5-HT3 receptor antagonists, but not associated with increases in urinary 5-HIAA. It is suggested that cyclophosphamide-induced emesis is not mediated by the release of serotonin from enterochromaffin cells. Although after high-dose cisplatin most emesis is sensitive to 5-HT3 receptor antagonists, patients often present a milder, although more prolonged form of emesis which is mostly resistant to 5-HT3 receptor antagonists (also known as 'delayed emesis'). This form of emesis is not associated with increases in urinary 5-HIAA (not due to serotonin released from the enterochromaffin cells). Treatment with p-chlorophenylalanine (a serotonin synthesis inhibitor) inhibited cisplatin-induced emesis and cisplatin-induced increases in urinary 5-HIAA excretion. In summary, these results indicate that in human patients, serotonin plays a fundamental role in chemotherapy-induced emesis. Serotonin released from enterochromaffin cells seems to mediate emesis sensitive to 5-HT3 receptor antagonists induced by cisplatin, dacarbazine and nitrogen mustard. Emesis sensitive to 5-HT3 receptor antagonists associated with cyclophosphamide treatment, is not mediated by the release of serotonin from enterochromaffin cells by the cytotoxic. Therefore, cyclophosphamide could induce serotonin release either from enteric serotonin nerves or from the CNS. Cisplatin-induced emesis resistant to 5-HT3 receptor antagonists ('delayed emesis') is not mediated by serotonin released from enterochromaffin cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692546     DOI: 10.1159/000227636

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  10 in total

1.  Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan.

Authors:  C Blandizzi; B De Paolis ; R Colucci; G Lazzeri; F Baschiera; M Del Tacca
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Treatment of chemotherapy-induced nausea and vomiting.

Authors:  Hanane Inrhaoun; Tamás Kullmann; Ibrahim Elghissassi; Hind Mrabti; Hassan Errihani
Journal:  J Gastrointest Cancer       Date:  2012-12

3.  Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.

Authors:  Hironori Nakamura; Haruko Yokoyama; Risa Takayanagi; Koichi Yoshimoto; Akihiro Nakajima; Kiyoshi Okuyama; Osamu Iwase; Yasuhiko Yamada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-01-28       Impact factor: 2.441

Review 4.  Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases.

Authors:  Mari Iwasaki; Yasutada Akiba; Jonathan D Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2019-07-10

5.  FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.

Authors:  Yasutada Akiba; Koji Maruta; Kazuyuki Narimatsu; Hyder Said; Izumi Kaji; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

6.  The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.

Authors:  Byung Gun Lim; Sang-Sik Choi; Yu Jin Jeong; Young Jin Lim; Yong Chul Kim; Kyoung Un Park; Dong Kyu Lee; Mi Kyoung Lee
Journal:  Korean J Anesthesiol       Date:  2014-12-29

7.  Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting.

Authors:  Gerald M Higa; Miklos L Auber; Gerry Hobbs
Journal:  Support Care Cancer       Date:  2012-02-14       Impact factor: 3.603

8.  Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.

Authors:  Agnes Glaus; Cornelia Knipping; Rudolf Morant; Christel Böhme; Burkhard Lebert; Frank Beldermann; Bernhard Glawogger; Paz Fernandez Ortega; André Hüsler; Robert Deuson
Journal:  Support Care Cancer       Date:  2004-10       Impact factor: 3.603

9.  Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model.

Authors:  Hyo-Seon Kim; Hyeong-Geug Kim; Hwi-Jin Im; Jin-Seok Lee; Sung-Bae Lee; Won-Yong Kim; Hye-Won Lee; Sam-Keun Lee; Chang Kyu Byun; Chang-Gue Son
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-08       Impact factor: 2.629

10.  Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression.

Authors:  H O Lawal; A Terrell; H A Lam; C Djapri; J Jang; R Hadi; L Roberts; V Shahi; M-T Chou; T Biedermann; B Huang; G M Lawless; N T Maidment; D E Krantz
Journal:  Mol Psychiatry       Date:  2012-12-11       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.